United States Smart Insulin Management Devices Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Abbott, Medtronic, Tandem Diabetes Care, Inc., Insulet Corporation

Smart Insulin Management Devices Market Size reached US$ 12.93 Billion in 2024 and is expected to reach US$ 27.07 Billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.

According to DataM Intelligence Comprehensive Report has released its latest report on the "Smart Insulin Management Devices Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/smart-insulin-management-devices-market?sg

USA - Industry Latest News 2025:

✅ 21 May 2025 - Medtronic plc announced plans to spin‐off its diabetes business (which includes insulin pumps, pens and related wearable/connected devices) into a separate publicly‐traded company within the next ~18 months.

✅ 7 Apr 2025 - At the ATTD 2025 conference, major highlights included progress in AI‐powered insulin automation (closed‐loop systems) and wearable insulin delivery systems.

✅ November 2025 - Tidepool (non‐profit) announced a partnership with Oura (smart ring maker) to pair biometric ring data with insulin pump/CGM data for diabetes research.

Korea - Industry Latest News 2025:

✅ 8 Sept 2025 - Huons Co., Ltd. confirmed its smart insulin pen DIA:CONN P8 (stage 4 pen‐shaped insulin delivery device) will be launched in Korea.

✅ 9 Jul 2025 - Health2Sync and Novo Nordisk Korea launched a "smart cap" for FlexTouch® pens, enabling dosage/time data capture via smartphone app integration (in Korea).

Europe - Industry Latest News 2025:

✅ June 2025 - Novo Nordisk released a smart reusable insulin pen in Europe that transmits dosing data to mobile applications for patients and clinicians.

✅ 23 Apr 2025 - Ypsomed Holding AG (Swiss diabetes‐device company) agreed to transfer its insulin‐pump/diabetes‐care arm to TecMed AG in a deal worth up to CHF 420 million (~US$ 513 m).

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/smart-insulin-management-devices-market?sg

Market Geographical Share:

North America dominates the smart insulin management devices market, accounting for the largest share globally. The growth is primarily fueled by a high prevalence of diabetes, awareness about diabetes management, and advanced healthcare infrastructure. The U.S. remains the leading market due to widespread adoption of insulin pumps and digital monitoring systems.

Europe holds the second-largest market share, with countries like Germany, the U.K., and France leading adoption. Supportive government policies, reimbursement schemes, and increasing patient awareness about smart diabetes management solutions contribute to growth in the region.

The Asia-Pacific market is emerging rapidly, driven by rising diabetes incidence, improving healthcare infrastructure, and growing disposable incomes in countries like China, India, and Japan. However, adoption is slower compared to North America due to cost sensitivity and limited awareness in rural areas.

Market Drivers:

✅ Rising Diabetes Prevalence:
The increasing number of diabetes patients globally drives the demand for effective and convenient insulin management solutions. Smart devices help improve patient compliance and reduce complications.

✅ Technological Advancements:
Integration of artificial intelligence, IoT-enabled devices, and mobile applications allows real-time monitoring, predictive analytics, and personalized insulin therapy, boosting adoption.

✅ Growing Awareness of Self-Management:
Patients and caregivers are becoming increasingly aware of the benefits of smart insulin devices, leading to higher adoption for better glycemic control and lifestyle management.

✅ Healthcare Infrastructure and Reimbursement Policies:
Supportive insurance coverage and government reimbursement policies, particularly in North America and Europe, encourage patients to invest in advanced insulin management systems.

✅ Rising Adoption of Connected Health Solutions:
The trend of digital health and connected devices in chronic disease management promotes the use of smart insulin devices as part of integrated diabetes care.

✅ Focus on Reducing Healthcare Costs:
By preventing diabetes-related complications through accurate insulin delivery and continuous monitoring, smart devices help reduce long-term healthcare costs, driving their adoption among healthcare providers and patients.

Segments Covered in the Beverage Premix Market:

By Product Type - Insulin Pen Injectors, Insulin Jet Injectors, Insulin Pumps, Insulin Patches, Others

By Application - Type I Diabetes, Type II Diabetes, Gestational Diabetes

By End-User - Hospitals, Home Care settings, Specialty Clinics, Others

Regional Analysis for Beverage Premix Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Buy Now & Get 30% OFF - Grab 50% OFF on 2+ reports: https://www.datamintelligence.com/buy-now-page?report=smart-insulin-management-devices-market?sg

Major Key Players: Abbott, Medtronic, Tandem Diabetes Care, Inc., Insulet Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, Ypsomed AG, i-SENS, Inc., and Diabeloop SA.

✅ Tandem Diabetes Care, Inc.: A U.S.-based insulin‐pump specialist recognised for its "t:slim" and Control‐IQ automated delivery systems; though exact market share isn't publicly detailed, it's cited among leading smart‐pump players.

✅ Insulet Corporation: Reports full‐year 2023 revenue growth of ~30%, reaching about US $1.7 billion, driven by its Omnipod tubeless pump system.

✅ Eli Lilly and Company: Identified among the top companies in the smart‐diabetes management market (devices + digital) alongside the likes of Novo Nordisk and Roche.

✅ Hoffmann‐La Roche Ltd: The diabetes‐care/devices arm of Roche appears in competitive analyses of insulin delivery/device markets as a key contributor.

✅ Novo Nordisk (A/S): Leads the insulin‐delivery device market in terms of share according to one report, and is noted for its strong portfolio of insulin pens among device/therapy companies.

✅ Ypsomed AG: A Swiss company focused on self‐administration delivery systems; cited as one of the key players in the insulin delivery devices market.

Unlimited Insights. One Subscription: https://www.datamintelligence.com/reports-subscription?sg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.